Fortis Healthcare share news, announcements and annual reports
NSE: FORTISBSE: 532843Healthcare ServicesMid Cap
Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹768.15up ₹13.25 (1.76%)BSE ₹769.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹754.90.
30 Oct: open ₹754.90, high ₹768.15, low ₹745.00
52-week range of traded prices to 30 Oct 2026
₹704.95Low, 23 Oct 2026₹1,057.45High, 30 Oct 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,992 Cr156th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 55.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.86
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,56,10356.9% delivered
Fortis Healthcare share news and announcements
1,301 announcements, routine notices left out, newest first. Page 20 of 27.
Jun 2013
10 Jun · Updates
Issue Committee of the Board of Directors of the Company has by a resolution dated June 08, 2013 allotted 550 foreign currency convertible bonds ("FCCBs") of the Company to International Finance Corporation, aggregating to US$ 55 million, in accordance with applicable law. The FCCBs have a par value of US$ 100,000 and are convertible into fully paid up equity shares of the Company. The floor price for the conversion of the FCCBs is Rs. 99.09 per equity share (determined in accordance with applicable law).6 Jun · Business
Issue Committee of the Board of Directors of Fortis Healthcare Limited (the "Company") has by a resolution dated June 06, 2013 allotted 18,833,700 equity shares of the Company to International Finance Corporation, on preferential basis, at an issue price of Rs.99.09 per equity share, aggregating to Rs.1,866,231,333, in accordance with applicable law.3 Jun · Updates
With reference to the earlier announcement dated May 09, 2013, the Company has now informed the Exchange that SEBI vide its approval dated June 03, 2013, has decided to accede the following :- (a) Promoter(s) be allowed to sell one equity share in the secondary market subject to the condition that any such sale shall be undertaken in a bona fide manner to unrelated non-promoter entities through the regular market segment. Further the Company has informed that, out of the shares held by Fortis Healthcare Holdings Private Limited, one equity share has also been sold in the secondary market to non-promoter entities through the regular market segment.
May 2013
24 May · Meeting
Shareholders of the Company approved Special Resolution under Section 81(1A) of the Companies Act, 1956, for raising additional funds through further issue of securities by way of Preferential Allotment to International Finance Corporation, at their Extra-ordinary General Meeting held on May 24, 2013.23 May · Board meeting
To inter alia, to approve the Audited Financial Results of the Company, for the financial year ended March 31, 2013.20 May · Updates
Issue Committee of the Board of Directors of the Company has by a resolution dated May 17, 2013, allotted 34,993,030 equity shares of the Company at an issue price of Rs. 92 per equity share, aggregating to Rs. 3,219.4 million, under the institutional placement programme undertaken by the Company in accordance with Chapter VIII-A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and the approvals granted by the Securities and Exchange Board of India pursuant to letters dated January 16, 2013, April 15, 2013 and May 9, 2013, as applicable.15 May · Updates
Issue Committee of the Board of Directors of the Company has, by a resolution dated May 14, 2013, finalised the issue price of Rs. 92 (Rupees Ninety Two only) per equity share to be issued by the Company pursuant to the institutional placement programme under Chapter VIII-A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 and in accordance with the approvals granted by the Securities and Exchange Board of India pursuant to letters dated January 16, 2013, April 15, 2013 and May 9, 2013.10 May · Board meeting
10 May · Updates
With reference to the earlier announcement dated April 15, 2013 regarding Relaxation from proposed Institutional Placement Programme (IPP), the Company has now informed the Exchange that SEBI vide its letter dated May 09, 2013, has decided to accede the following :- (a) Company be allowed to allot not more than 50% of the offer size to the specified investor, along with the minimum of ten allottees in the proposed IPP with not more than 25% of the offer size to any other investor; (b) The pricing in the proposed IPP will be as per Chapter VIII A of ICDR Regulation; (c) In case of excess allocation to the investor referred to (a) above, the shares allotted to that investor shall be subject to lock in as per Regulation 78(2) of SEBI (ICDR) Regulations, 2009
Apr 2013
17 Apr · Business
Human Resources and Remuneration Committee of the Company has, allotted 4,900 Equity Shares of Rs. 10/- each on April 15, 2013, to the grantees, upon exercise of vested stock options, under the "Employee Stock Option Plan 2007" of the Company. Consequent to the said allotment, the paid-up equity share capital of the Company has gone upto Rs. 4,052,122,350/- divided into 405,212,235 equity shares of Rs. 10/- each.16 Apr · Updates
With continuation to the earlier announcement dated January 22, 2013,the company has now informed that SEBI vide its letter dated April 15, 2013, has also relaxed the restriction on the minimum number of allottees for a proposed Institutional Placement Programme (IPP) by the Company. The minimum number of allottees for a proposed IPP by the Company may be less than 10 in line with the extant provisions on minimum number of allottees in a qualified institutions placement (QIP). However, the proposed IPP will be subject to the pricing provisions as applicable to a QIP.
Mar 2013
13 Mar · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2012. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2013
26 Feb · Business
Human Resources and Remuneration Committee of the Company has on February 25, 2013, allotted 3,900 Equity Shares of Rs.10/- each, to the grantees, upon exercise of vested stock options, under the "Employee Stock Option Plan 2007" of the Company. Consequent to the said allotment, the paid-up equity share capital of the Company has gone upto Rs. 4,052,073,350/- divided into 405,207,335 equity shares of Rs.10/- each.1 Feb · Board meeting
To inter alia, approve the Un-audited Financial Results of the Company, for the Quarter ended December 31, 2012.
Jan 2013
22 Jan · Updates
In continuance with our intimation dated November 27, 2012 read with further clarification dated December 26, 2012, please note that, the SEBI vide its letter no. CFD/POLICYCELL/1566/2013, has accorded its consent:- (1)To issue equity shares upto 10% of post issue capital to qualified institutional buyers under Chapter Vlll-A of SEBI (ICDR) Regulations, 2009; (2) Allowing limited reviewed consolidated financial statements for the stub period for inclusion in the offer Document, in case the Company opts for proposed issue of Equity Shares through an Institutional Placement Programme (IPP) for meeting minimum public shareholding threshold
Dec 2012
27 Dec · Address Change
Change in correspondence address of Company's Registrar and Transfer Agent - M/s. Link Intime India Private Limited. The new correspondence address is: M/s. Link Intime India Private Limited, 44, Community Centre, 2nd Floor, Naraina Industrial Area, Phase -1, Near PVR Naraina, New Delhi- 110028.26 Dec · News Verification
News Verification : The media had reports that the promoters are planning to sell their stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Fortis Healthcare Limited has vide its letter inter-alia stated, "We wish to submit that the Board of Directors of the Company has constituted an Issue Committee to evaluate various options available in order to comply with the minimum public shareholding requirement as specified under the Securities Contract (Regulation) Rules, 1957, and Clause 40A of the Equity Listing Agreement. The company is in the process of evaluating various options available under the prevailing regulatory framework. Till date no final decision in this regard has been made and we will keep Stock Exchanges updated on any further material development".